Ignite Creation Date:
2025-12-25 @ 2:29 AM
Ignite Modification Date:
2026-01-08 @ 3:31 AM
Study NCT ID:
NCT01397734
Status:
TERMINATED
Last Update Posted:
2018-09-06
First Post:
2011-07-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
Sponsor:
Beth Israel Deaconess Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09
Start Date Type:
None
Primary Completion Date:
2018-08-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-06
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-18
First Submit QC Date:
None
Study First Post Date:
2011-07-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-04
Last Update Post Date:
2018-09-06
Last Update Post Date Type:
ACTUAL